GenFleet Reports Progress on 2026 H-Share Buyback: 872,000 Shares Repurchased, Equal to 0.227% of Share Capital

Bulletin Express09-21

GenFleet Therapeutics (Shanghai) Inc. disclosed that, as of 18 September 2026, it has repurchased an aggregate 872,000 H shares on The Stock Exchange of Hong Kong Limited under its 2026 buyback programme. The volume represents approximately 0.227% of the company’s total issued share capital.

The ongoing repurchase activity is conducted under the general mandate approved by shareholders at the 11 May 2026 annual general meeting. The board retains full discretion over the timing, quantity and pricing of any further buybacks, which will continue to depend on prevailing market conditions.

GenFleet emphasised that there is no assurance regarding the scale or schedule of future repurchases and advised shareholders and potential investors to exercise caution when trading the company’s H shares.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment